We first evaluated expression of KDM3A mRNA in MM patient samples using publicly available gene expression profiling data because this jumonji demethylase has been implicated in the pathogenesis of several other cancers13, 14, 15, 16, 17. The gene discussed is KDM3A; the disease is Miyoshi myopathy.